Department for Health, University of Bath
Bath, BA2 7AY, United Kingdom
NCT Number: NCT02852044
For decades, it has been known that post-meal blood glucose concentrations were associated with the risk of T2D, which was reflected in early diagnostic guidelines. The oral glucose tolerance test (OGTT) has been used since at least 1923 and has remained the most common test for assessing glucose tolerance. Arterial blood (or arterialised blood using heated hand technique) is most appropriate for determining glucose tolerance and insulin sensitivity since this best represents the concentrations of metabolites and hormones that peripheral tissues are exposed to. It is essential to investigate whether venous blood (sometimes used during an OGTT) is representative of arterialised blood during an OGTT, and under different metabolic conditions.
The investigators want to understand whether OGTT-derived insulin sensitivity indices differ from venous and arterialised blood; and 2) investigate whether metabolic status (i.e. rest vs lower-limb exercise) influences the difference between forearm venous and arterialised concentrations of glucose and insulin during an OGTT.
Looking for future studies?
Notify Me18 year–49 year
Male
Interventional
Not applicable
Bath, BA2 7AY, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Allowed to watch television or read for one hour prior to oral glucose tolerance test
One hour of cycling at 50% of maximal power output
Time frame: 120 mins
Time frame: 120 mins
Time frame: 5 mins
Time frame: 5 mins
Time frame: 5 mins
Time frame: 5 mins
Time frame: 120 mins
Time frame: 120 mins
Time frame: 180 mins
Time frame: 120 mins
University of Bath
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01804738
Glucose Metabolism Disorders, Hyperglycemia
Singapore
View Trial DetailsNCT02248272
Adnexal Diseases, Cysts
View Trial DetailsNCT02653677
Glucose Metabolism Disorders, Hyperglycemia
View Trial DetailsNCT01405547
Body Weight, Diabetes Mellitus
Toronto, Ontario, Canada
View Trial Details